Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s10620-015-3797-3, but it redirected us to https://link.springer.com/article/10.1007/s10620-015-3797-3. The analysis below is for the second page.

Title[redir]:
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease | Digestive Diseases and Sciences
Description:
The gastrointestinal (GI) microbiome is recognized for potential clinical relevance in inflammatory bowel disease (IBD). Data suggest that there is a disease-dependent loss of microbial diversity in IBD. Trimethylamine-N-oxide (TMAO) is generated by GI anaerobes through the digestion of dietary phosphatidylcholine and carnitine in a microbial-mammalian co-metabolic pathway. IBD-related changes in the gut microbiome may result in disease-specific changes in TMAO plasma concentrations. To determine whether TMAO plasma levels in IBD are altered compared to controls and whether they correlate with disease presence or activity. Liquid chromatography–tandem mass spectrometry was used to measure TMAO, choline, and carnitine plasma levels in 479 subjects (373 non-IBD controls, 106 IBD). Subjects were also genotyped for the flavin monooxygenase (FMO)3 variants, E158K and E308G. Plasma TMAO levels were 2.27 µM lower in the IBD population compared to the control population (p = 0.0001). Lower TMAO levels were similarly seen in active ulcerative colitis (UC) (1.56 µM) versus inactive disease (3.40 µM) (p = 0.002). No difference was seen in active Crohn’s disease (CD) versus inactive CD. No intergroup variation existed in plasma TMAO levels based on FMO3 genotype. Choline levels were higher in IBD, while carnitine levels were similar between the two groups, suggesting that lower TMAO levels in IBD were not due to dietary differences. Decreased TMAO levels are seen in IBD compared to a non-IBD population. These data suggest that TMAO may have potential as a biomarker to support IBD diagnosis as well as to assess disease activity in UC.

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,420 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

article, pubmed, google, scholar, cas, bowel, disease, inflammatory, central, gut, microbiome, tmao, ibd, levels, microbiota, intestinal, human, diseases, microbial, trimethylaminenoxide, activity, gastroenterology, dis, nature, research, study, inflamm, department, western, university, london, privacy, cookies, content, analysis, data, wilson, clinical, diversity, plasma, fmo, colitis, crohns, access, med, wang, metabolism, medicine, canada, publish,

Topics {✒️}

article  google scholar month download article/chapter trimethylamine-n-oxide production short-chain fatty acid active ulcerative colitis article digestive diseases trimethylamine-n-oxide crohn’s-disease activity full article pdf yun-hee choi inflammatory bowel disease bmc res notes privacy choices/manage cookies inflammatory bowel diseases bennett bj gut microbial–mammalian apical membrane vesicles inflamm bowel dis irritable bowel syndrome versus inactive disease assess disease activity microbial community imbalances patel na medical sciences building article wilson rat distal colon tmao plasma levels disease-dependent loss tmao plasma concentrations culture-independent analysis human gut microbiota european economic area c-reactive protein northern european countries hum mol genet glycyl radical enzyme da costa ka cancer care ontario ethics declarations conflict gut microbiome structure pharmacol exp therap conditions privacy policy population-based study intergroup variation existed molecular-phylogenetic characterization custom phylogenetic microarray van erpecum kj van mil sw lower tmao levels human gut microbiome

Questions {❓}

  • The manitoba inflammatory bowel disease cohort study: prolonged symptoms before diagnosis—how much is irritable bowel syndrome?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease
         description:The gastrointestinal (GI) microbiome is recognized for potential clinical relevance in inflammatory bowel disease (IBD). Data suggest that there is a disease-dependent loss of microbial diversity in IBD. Trimethylamine-N-oxide (TMAO) is generated by GI anaerobes through the digestion of dietary phosphatidylcholine and carnitine in a microbial-mammalian co-metabolic pathway. IBD-related changes in the gut microbiome may result in disease-specific changes in TMAO plasma concentrations. To determine whether TMAO plasma levels in IBD are altered compared to controls and whether they correlate with disease presence or activity. Liquid chromatography–tandem mass spectrometry was used to measure TMAO, choline, and carnitine plasma levels in 479 subjects (373 non-IBD controls, 106 IBD). Subjects were also genotyped for the flavin monooxygenase (FMO)3 variants, E158K and E308G. Plasma TMAO levels were 2.27 µM lower in the IBD population compared to the control population (p = 0.0001). Lower TMAO levels were similarly seen in active ulcerative colitis (UC) (1.56 µM) versus inactive disease (3.40 µM) (p = 0.002). No difference was seen in active Crohn’s disease (CD) versus inactive CD. No intergroup variation existed in plasma TMAO levels based on FMO3 genotype. Choline levels were higher in IBD, while carnitine levels were similar between the two groups, suggesting that lower TMAO levels in IBD were not due to dietary differences. Decreased TMAO levels are seen in IBD compared to a non-IBD population. These data suggest that TMAO may have potential as a biomarker to support IBD diagnosis as well as to assess disease activity in UC.
         datePublished:2015-07-10T00:00:00Z
         dateModified:2015-07-10T00:00:00Z
         pageStart:3620
         pageEnd:3630
         sameAs:https://doi.org/10.1007/s10620-015-3797-3
         keywords:
            Inflammatory bowel disease
            Biomarker
            Trimethylamine-N-oxide
            Microbial-mammalian co-metabolism
            Gastroenterology
            Hepatology
            Oncology
            Transplant Surgery
            Biochemistry
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig7_HTML.gif
         isPartOf:
            name:Digestive Diseases and Sciences
            issn:
               1573-2568
               0163-2116
            volumeNumber:60
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Aze Wilson
               affiliation:
                     name:Western University
                     address:
                        name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
                     name:Western University
                     address:
                        name:Division of Gastroenterology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
                     name:Western University
                     address:
                        name:Department of Physiology and Pharmacology, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wendy A. Teft
               affiliation:
                     name:Western University
                     address:
                        name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bridget L. Morse
               affiliation:
                     name:Western University
                     address:
                        name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yun-Hee Choi
               affiliation:
                     name:Western University
                     address:
                        name:Department of Epidemiology and Biostatistics, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sarah Woolsey
               affiliation:
                     name:Western University
                     address:
                        name:Department of Physiology and Pharmacology, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marianne K. DeGorter
               affiliation:
                     name:Western University
                     address:
                        name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert A. Hegele
               affiliation:
                     name:Western University
                     address:
                        name:Division of Endocrinology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rommel G. Tirona
               affiliation:
                     name:Western University
                     address:
                        name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
                     name:Western University
                     address:
                        name:Department of Physiology and Pharmacology, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Richard B. Kim
               affiliation:
                     name:Western University
                     address:
                        name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease
      description:The gastrointestinal (GI) microbiome is recognized for potential clinical relevance in inflammatory bowel disease (IBD). Data suggest that there is a disease-dependent loss of microbial diversity in IBD. Trimethylamine-N-oxide (TMAO) is generated by GI anaerobes through the digestion of dietary phosphatidylcholine and carnitine in a microbial-mammalian co-metabolic pathway. IBD-related changes in the gut microbiome may result in disease-specific changes in TMAO plasma concentrations. To determine whether TMAO plasma levels in IBD are altered compared to controls and whether they correlate with disease presence or activity. Liquid chromatography–tandem mass spectrometry was used to measure TMAO, choline, and carnitine plasma levels in 479 subjects (373 non-IBD controls, 106 IBD). Subjects were also genotyped for the flavin monooxygenase (FMO)3 variants, E158K and E308G. Plasma TMAO levels were 2.27 µM lower in the IBD population compared to the control population (p = 0.0001). Lower TMAO levels were similarly seen in active ulcerative colitis (UC) (1.56 µM) versus inactive disease (3.40 µM) (p = 0.002). No difference was seen in active Crohn’s disease (CD) versus inactive CD. No intergroup variation existed in plasma TMAO levels based on FMO3 genotype. Choline levels were higher in IBD, while carnitine levels were similar between the two groups, suggesting that lower TMAO levels in IBD were not due to dietary differences. Decreased TMAO levels are seen in IBD compared to a non-IBD population. These data suggest that TMAO may have potential as a biomarker to support IBD diagnosis as well as to assess disease activity in UC.
      datePublished:2015-07-10T00:00:00Z
      dateModified:2015-07-10T00:00:00Z
      pageStart:3620
      pageEnd:3630
      sameAs:https://doi.org/10.1007/s10620-015-3797-3
      keywords:
         Inflammatory bowel disease
         Biomarker
         Trimethylamine-N-oxide
         Microbial-mammalian co-metabolism
         Gastroenterology
         Hepatology
         Oncology
         Transplant Surgery
         Biochemistry
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-015-3797-3/MediaObjects/10620_2015_3797_Fig7_HTML.gif
      isPartOf:
         name:Digestive Diseases and Sciences
         issn:
            1573-2568
            0163-2116
         volumeNumber:60
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Aze Wilson
            affiliation:
                  name:Western University
                  address:
                     name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
                  name:Western University
                  address:
                     name:Division of Gastroenterology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
                  name:Western University
                  address:
                     name:Department of Physiology and Pharmacology, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wendy A. Teft
            affiliation:
                  name:Western University
                  address:
                     name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bridget L. Morse
            affiliation:
                  name:Western University
                  address:
                     name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yun-Hee Choi
            affiliation:
                  name:Western University
                  address:
                     name:Department of Epidemiology and Biostatistics, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sarah Woolsey
            affiliation:
                  name:Western University
                  address:
                     name:Department of Physiology and Pharmacology, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marianne K. DeGorter
            affiliation:
                  name:Western University
                  address:
                     name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert A. Hegele
            affiliation:
                  name:Western University
                  address:
                     name:Division of Endocrinology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rommel G. Tirona
            affiliation:
                  name:Western University
                  address:
                     name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
                  name:Western University
                  address:
                     name:Department of Physiology and Pharmacology, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Richard B. Kim
            affiliation:
                  name:Western University
                  address:
                     name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Digestive Diseases and Sciences
      issn:
         1573-2568
         0163-2116
      volumeNumber:60
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Western University
      address:
         name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Gastroenterology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Department of Physiology and Pharmacology, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Department of Epidemiology and Biostatistics, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Department of Physiology and Pharmacology, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Endocrinology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Department of Physiology and Pharmacology, Western University, London, Canada
         type:PostalAddress
      name:Western University
      address:
         name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Aze Wilson
      affiliation:
            name:Western University
            address:
               name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
            name:Western University
            address:
               name:Division of Gastroenterology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
            name:Western University
            address:
               name:Department of Physiology and Pharmacology, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Wendy A. Teft
      affiliation:
            name:Western University
            address:
               name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Bridget L. Morse
      affiliation:
            name:Western University
            address:
               name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Yun-Hee Choi
      affiliation:
            name:Western University
            address:
               name:Department of Epidemiology and Biostatistics, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Sarah Woolsey
      affiliation:
            name:Western University
            address:
               name:Department of Physiology and Pharmacology, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Marianne K. DeGorter
      affiliation:
            name:Western University
            address:
               name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Robert A. Hegele
      affiliation:
            name:Western University
            address:
               name:Division of Endocrinology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Rommel G. Tirona
      affiliation:
            name:Western University
            address:
               name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
            name:Western University
            address:
               name:Department of Physiology and Pharmacology, Western University, London, Canada
               type:PostalAddress
            type:Organization
      name:Richard B. Kim
      affiliation:
            name:Western University
            address:
               name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
      name:Division of Gastroenterology, Department of Medicine, Western University, London, Canada
      name:Department of Physiology and Pharmacology, Western University, London, Canada
      name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
      name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
      name:Department of Epidemiology and Biostatistics, Western University, London, Canada
      name:Department of Physiology and Pharmacology, Western University, London, Canada
      name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
      name:Division of Endocrinology, Department of Medicine, Western University, London, Canada
      name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
      name:Department of Physiology and Pharmacology, Western University, London, Canada
      name:Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(278)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.34s.